SCHEMBL30537835

CC(C)C[C@H](NC(=O)[C@H](CO)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CCC(N)=O)[C@@H](C)O)C(N)=O

nearest known ligand 0.64

Predicted protein targets (top 9)

	gene	UniProt	supporting neighbours	confidence
▸	NPY4R	P50391	11/20	0.60

▸	NPY1R	P25929	6/20	0.60

▸	NPY2R	P49146	4/20	0.60

▸	NPY5R	Q15761	4/20	0.60

▸	KISS1R	Q969F8	3/20	0.60

▸	TFPI	P10646	1/20	0.59

▸	OPRM1	P35372	1/20	0.58

▸	OPRD1	P41143	1/20	0.58

▸	OPRK1	P41145	1/20	0.58

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compound	similarity	top predicted	shared targets
SCHEMBL30537834	0.99	TFPI (0.60)	NPY4RNPY1RNPY2RNPY5RKISS1R
SCHEMBL30537833	0.93	TFPI (0.61)	NPY4RNPY1RNPY2RNPY5RKISS1R
SCHEMBL26057785	0.92	TFPI (0.62)	NPY4RNPY1RNPY2RNPY5RKISS1R
SCHEMBL31430943	0.91	NPY4R (0.64)	NPY4RNPY1RNPY2RNPY5RKISS1R
SCHEMBL31415952	0.88	NPY4R (0.58)	NPY4RNPY1RNPY2RNPY5R
SCHEMBL6471509	0.88	NPY4R (0.62)	NPY4RNPY1RNPY2RNPY5RKISS1R
SCHEMBL6471503	0.88	NPY4R (0.62)	NPY4RNPY1RNPY2RNPY5RKISS1R
SCHEMBL31430937	0.88	NPY4R (0.68)	NPY4RNPY1RNPY2RNPY5RKISS1R
SCHEMBL16508068	0.87	NPY4R (0.61)	NPY4RNPY1RNPY2RNPY5RKISS1R
SCHEMBL16508070	0.87	NPY4R (0.61)	NPY4RNPY1RNPY2RNPY5RKISS1R

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

Patent	Title	Assignee	Published	Priority	Filing	Country	Status
WO-2023161311-A1	ANTI-INFECTIVE CONJUGATE FOR USE IN THE TREATMENT OF ZIKA VIRUS INFECTION	UNIVERSITAT POMPEU FABRA (ES)	2023-08-31	—	—	WO	claimed